Springer Nature has joined the Pistoia Alliance to collaborate with the wider life science community to advance discovery and research solutions. As part of its commitment to developing innovative solutions to support research and researcher needs, Springer Nature has joined the Pistoia Alliance, a global initiative to drive forward best practices, standards and technology in the life sciences.
The Pistoia Alliance was formed by global pharmaceutical companies including Pfizer, GlaxoSmithKline, Novartis and AstraZeneca with the purpose of helping researchers overcome common obstacles to innovation whether this is identifying the root causes of inefficiencies, working with regulators to adopt new standards, or helping researchers implement AI effectively.
The partnership will see Springer Nature work collaboratively with Pistoia and its members, sharing knowledge and contributing to Pistoia’s community projects to better address the practical needs of researchers within these critical fields.
Click here to read the original press release.
